| [8] |
Bucciarelli P, Rosendaal FR, Tripodi A, et al. Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study[J]．Arterioscler Thromb Vasc Biol，1999，19(4)：1026-1033.
|
| [9] |
Sanson BJ, Simioni P, Tormene D, et al. The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study[J]．Blood，1999，94(11)：3702-3706.
|
| [10] |
Tang L, Hu Y. Ethnic diversity in the genetics of venous thromboembolism[J]．Thromb Haemost，2015，114(5)：901-909.
|
| [11] |
American College of Obstetricians and Gynecologists′ Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 197: inherited thrombophilias in pregnancy[J]. Obstet Gynecol，2018，132(1)：e18-e34.
|
| [12] |
Tang L, Guo T, Yang R, et al. Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombosis in Chinese population[J]．PLoS One，2012，7(4)：1-9.
|
| [13] |
Tang L, Lu X, Yu JM, et al. PROC c．574_576del polymorphism: a common genetic risk factor for venous thrombosis in the Chinese population [J]．J Thromb Haemost，2012，10(10)：2019-2026.
|
| [14] |
Tang L, Wang HF, Lu X, et al. Common genetic risk factors for venous thrombosis in the Chinese population[J]．Am J Hum Genet，2013，92(2)：177-187.
|
| [15] |
Armstrong EM, Bellone JM, Hornsby LB, et al. Acquired thrombophilia[J]．J Pharm Pract，2014，27(3)：234-242.
|
| [16] |
Galambosi PJ，Ulander VM，Kaaja RJ.The incidence and risk factors of recurrentvenous thromboembolism during pregnancy[J]．Thromb Res，2014，134(2)：240-245.
|
| [17] |
Simcox LE，Ormesher L，Tower C，et al. Thrombophilia and pregnancy complication[J]．Int J Mol Sci，2015，16(12)：28418-28428.
|
| [18] |
中华医学会血液学分会血栓与止血学组．易栓症诊断与防治中国指南(2021年版)[J]，中华血液学杂志，2021，42(11)：881-888.
|
| [19] |
American College of Obstetricians and Gynecologists′ Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 196: thromboembolism in pregnancy[J]. Obstet Gynecol，2018，132(1)：e1-e17.
|
| [20] |
Gherman RB, Goodwin TM, Leung T, et al. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy [J]. Prim Care Update Ob Gyns，1998，5(4)：155-156.
|
| [21] |
Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patters of venous thromboembolism in pregnancy and puerperium: a register-based case-control study[J]．Am J Obstet Gynecol，2008，198：233-234.
|
| [22] |
Sibai B, Dekker G, Kupferminc M. Pre-eclampsia[J]．The Lancet，2005，365(9461)：785-799.
|
| [23] |
Brown MA，Magee LA，Kenny LC，et al. The hypertensive disorders of pregnancy：ISSHP classification，diagnosis & management recommendations for international practice[J]．Pregnancy Hypertens，2018，13：291-310.
|
| [24] |
Magee LA, Nicolaides KH, Von Dadelszen P. Preeclampsia[J]．New England Journal of Medicine，2022，386(19)：1817-1832.
|
| [25] |
Kelliher S, Maguire PB, Szklanna PB, et al. Pathophysiology of the venous thromboembolism risk in preeclampsia[J]．Hämostaseologie，2020，40(5)：594-604.
|
| [26] |
Kevane B, Donnelly J, D’Alton M, et al. Risk factors for pregnancy-associated venous thromboembolism: a review[J]. Perinat Med，2014，42(4)：417-425.
|
| [27] |
Jacobsen AF, Skjeldestad FE, Sandset PM. Ante and postnatal risk factors of venous thrombosis: a hospital-based casecontrol study[J]．Thromb Haemost，2008，6(6)：905- 912.
|
| [28] |
Lindqvist P, Dahlbäck B, Marŝál K. Thrombotic risk during pregnancy: a population study[J]．Obstet Gynecol，1999，94(4)：595-599.
|
| [29] |
Mello G, Parretti E, Marozio L, et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study[J]．Hypertension，2005，46(6)：1270-1274.
|
| [30] |
Fernández Arias M, Mazarico E, Gonzalez A, et al. Genetic risk assessment of thrombophilia in patients with adverse obstetric outcomes[J]．PLoS One，2019，14(2)：1-9.
|
| [31] |
Dizon-Townson DS, Nelson LM, Easton K, et al. The factor V Leiden mutation may predispose women to severe preeclampsia[J]．American Journal of Obstetrics and Gynecology，1996，175(4)：902-905.
|
| [32] |
Rigó J Jr, Nagy B, Fintor L, et al. Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5, 10 methylenetetrahydrofolate reductase [J]．Hypertens Pregnancy，2000，19(2)：163-172.
|
| [33] |
Lin J, August P. Genetic thrombo philias and preeclampsia: a meta analysis[J]．Obstetrics & Gynecology，2005，105(1)：182-192.
|
| [34] |
Dizon-Townson D, Miller C, Sibai B, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus[J]．Obstet Gynecol，2005，106(3)：517-524.
|
| [35] |
Kjellberg U, van Rooijen M, Bremme K, et al. Factor V Leiden mutation and pregnancy-related complications[J]．Am J Obstet Gynecol，2010，203(5)：469.e1-469.e8.
|
| [36] |
Silver RM, Zhao Y, Spong CY, et al. Prothrombin gene G20210A mutation and obstetric complications[J]．Obstet Gynecol，2010，115(1)：14-20.
|
| [37] |
Dekker GA, De Vries JIP, Doelitzsch PM, et al. Underlying disorders associated with severe early-onset preeclampsia[J]．Am J Obstet Gynecol，1995，173(4)：1042-1048.
|
| [38] |
Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome(APS) [J]. J Thromb Haemost，2006，4(2)：296-306.
|
| [39] |
Uthman I, Noureldine MHA, RuizIrastorza G, et al. Management of antiphospholipid syndrome[J]．Ann Rheum Dis，2019，78(2)：155-161.
|
| [1] |
Egeberg O. Inherited antithrombin deficiency causing hrombophilia[J]．Thromb Diath Haemorrh，1965，13：516530.
|
| [2] |
Chiasakul T, De Jesus E, Tong J, et al. Inherited thrombophilia and the risk of arterial ischemic stroke: a systematic review and meta-analysis[J]．J Am Heart Assoc，2019，8(19)：1-51.
|
| [3] |
Connors JM. Thrombophilia Testing and Venous Thrombosis[J]．N Engl J Med，2017，377(12)：1177-1187.
|
| [4] |
Ormesher L, Simcox L, Tower C, et al. Management of inherited thrombophilia in pregnancy[J]．Womens Health (Lond)，2016，12(4)：433-441.
|
| [5] |
Ridker PM, Miletich JP, Hennekens CH, et al. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening[J]. JAMA，1997，277(16)：1305-1307.
|
| [6] |
Martinelli I, Mannucci PM, De Stefano V, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families[J]．Blood，1998，92(7)：2353-2358.
|
| [7] |
Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men[J]. Circulation，1999，99(8)：999-1004.
|
| [40] |
Sciascia S, Amigo MC, Roccatello D，et al.Diagnosing antiphospholipid syndrome: 'extra-criteria’ manifestations and technical advances [J]. Nat RevRheumatol，2017，13(9)：548-560.
|
| [41] |
Canaud G，Legendre C，Terzi F．AKT/mTORC pathway in antiphospholipid-related vasculopathy: a new player in the game [J]．Lupus，2015，24(3)：227-230.
|
| [42] |
Nayfe R, Uthman I, Aoun J, et al.Seronegative antiphospholipid syndrome [J]．Rheumatology (Oxford)，2013，52(8)：1358-1367.
|
| [43] |
Liu L, Sun D. Pregnancy outcomes in patients with primary antiphospholipid syndrome: a systematic review and meta-analysis[J]．Medicine，2019，98(20)：1-9.
|
| [44] |
Zemet R, Dulitzki M, Baum M, et al. Early-onset preeclampsia-The impact of antiphospholipid antibodies on disease severity [J]．Obstet Gynecol Reprod Biol，2021，263：79-84.
|
| [45] |
Marchetti T, De Moerloose P, Gris JC. Antiphospholipid antibodies and the risk of severe and non-severe pre-eclampsia: the NOHA case control study [J]. Journal of Thrombosis and Haemostasis，2016，14(4)：675-684.
|
| [46] |
Wang J, Trudinger B, Duarte N, et al. Elevatedirculating homocysteine levels in placental vascular diseasend associated preeclampsia [J]．BJOG，2000，107(7)：935-938.
|
| [47] |
Acılmıs YG, Dikensoy E, Kutlar AI, et al. Homocysteine, folic acid and vitamin B12 levels in maternal and umbilical cord plasma and homocysteine levels in placenta in pregnant women with pre-eclampsia[J]. J Obstet Gynaecol Res，2011，37(1)：45-50.
|
| [48] |
Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies [J]. J Thromb Haemost，2005，3(2)：292-299.
|
| [49] |
Kujovich JL. Factor V Leiden thrombophilia [J]．Genet Med，2011，13(1)：1-16.
|
| [50] |
Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J]. Chest，2012，141(2)：e691S-e736S.
|
| [51] |
Royal College of Obstetricians and Gynaecologists. Green Top Guideline No.37a：reducing the risk of venous thromboembolism during pregnancy and the puerperium. 3th ed. 2015：1-40.
|
| [52] |
American College of Obstetricians and Gynecologists′ Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 197: inherited thrombophilias in pregnancy [J]. Obstet Gynecol，2018，132(1)：e18-e34.
|
| [53] |
Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin [J]．Am J Obstet Gynecol，2022，226(2S)：S1108-S1119.
|
| [54] |
Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia [J]．N Engl J Med，2017，377(7)：613-622
|
| [55] |
朱毓纯，杨慧霞．小剂量阿司匹林预防子痫前期 [J]．中华围产医学杂志，2015，18(1)：3-4.
|
| [56] |
Gris JC, Chauleur C, Faillie JL, et al. Enoxaparin for thesecondary prevention of placental vascular complications inwomen with abruptio placentae. The pilot randomized controlled NOH-AP trial [J]．Thromb Haemost，2010，104(4)：771-779.
|
| [57] |
Rodger MA, Gris JC, de Vries JIP, et al. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials [J]．Lancet, 2016，388(10060)：2629-2641.
|
| [58] |
Cruz-Lemini M, Vázquez JC, Ullmo J, et al. Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis [J]．Am J Obstet Gynecol，2022，226(2S): S1126-S1144.e17.
|